0000899140-19-000232.txt : 20190214 0000899140-19-000232.hdr.sgml : 20190214 20190214150807 ACCESSION NUMBER: 0000899140-19-000232 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190214 DATE AS OF CHANGE: 20190214 GROUP MEMBERS: POINT72 CAPITAL ADVISORS, INC. GROUP MEMBERS: STEVEN A. COHEN SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Summit Therapeutics plc CENTRAL INDEX KEY: 0001599298 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-88759 FILM NUMBER: 19605126 BUSINESS ADDRESS: STREET 1: 136A EASTERN AVENUE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4SB BUSINESS PHONE: 44-123-544-3939 MAIL ADDRESS: STREET 1: 136A EASTERN AVENUE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4SB FORMER COMPANY: FORMER CONFORMED NAME: Summit Corp plc DATE OF NAME CHANGE: 20140205 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Point72 Asset Management, L.P. CENTRAL INDEX KEY: 0001603466 IRS NUMBER: 465064661 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 72 CUMMINGS POINT ROAD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 203-890-2000 MAIL ADDRESS: STREET 1: 72 CUMMINGS POINT ROAD CITY: STAMFORD STATE: CT ZIP: 06902 SC 13G/A 1 p28080265.htm SCHEDULE 13G/A, #4

240.13d-102 Schedule 13G - Information to be included in statements filed
pursuant to 240.13d-1(b), (c), and (d) and amendments thereto
filed pursuant to 240.13d-2.

Securities and Exchange Commission, Washington, D.C. 20549


Schedule 13G
Under the Securities Exchange Act of 1934
(Amendment No. 4)*
(Name of Issuer)
Summit Therapeutics PLC
(Title of Class of Securities)

Common Stock, Par Value $1.0 Per Share1

(CUSIP Number)

86627R1022

 (Date of Event Which Requires Filing of this Statement)

December 31, 2018

Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:

[  ] Rule 13d-1(b)
[ x ] Rule 13d-1(c)
[  ] Rule 13d-1(d)


*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be
deemed to be “filed” for the purpose of Section 18 of the Securities Exchange
Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the
Act but shall be subject to all other provisions of the Act (however, see
the Notes).





______________________
1The holdings reported herein are in the form of American Depositary Shares ("ADS"), which may
be exchanged for ordinary shares of the Issuer, par value £.01 ("Ordinary Shares") at a 1:5 ratio.
2The CUSIP Number listed throughout this filing is the CUSIP assigned to the ADS of the Issuer.

1



CUSIP No. 86627R102
(1) Names of reporting persons    Point72 Asset Management, L.P.
 
(2) Check the appropriate box if a member of a group
(a)
(see instructions)
(b)X
(3) SEC use only
 
(4) Citizenship or place of organization  Delaware
 
Number of shares beneficially owned by each reporting person with:
 
(5) Sole voting power                  0
 
(6) Shared voting power              2,229,955 (see Item 4)
 
(7) Sole dispositive power           0
 
(8) Shared dispositive power       2,229,955 (see Item 4)
 
(9) Aggregate amount beneficially owned by each reporting person
2,229,955 (see Item 4)
 
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)
 
(11) Percent of class represented by amount in Row (9)     2.7% (see Item 4)
 
(12) Type of reporting person (see instructions)     PN
 



2

CUSIP No. 86627R102
(1) Names of reporting persons    Point72 Capital Advisors, Inc.
 
(2) Check the appropriate box if a member of a group
(a)
(see instructions)
(b)X
(3) SEC use only
 
(4) Citizenship or place of organization  Delaware
 
Number of shares beneficially owned by each reporting person with:
 
(5) Sole voting power                  0
 
(6) Shared voting power              2,229,955 (see Item 4)
 
(7) Sole dispositive power           0
 
(8) Shared dispositive power       2,229,955 (see Item 4)
 
(9) Aggregate amount beneficially owned by each reporting person
2,229,955 (see Item 4)
 
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)
 
(11) Percent of class represented by amount in Row (9)     2.7% (see Item 4)
 
(12) Type of reporting person (see instructions)     CO
 



3

CUSIP No. 86627R102
(1) Names of reporting persons    Steven A. Cohen
 
(2) Check the appropriate box if a member of a group
(a)
(see instructions)
(b)X
(3) SEC use only
 
(4) Citizenship or place of organization  United States
 
Number of shares beneficially owned by each reporting person with:
 
(5) Sole voting power                  0
 
(6) Shared voting power              2,229,955 (see Item 4)
 
(7) Sole dispositive power           0
 
(8) Shared dispositive power       2,229,955 (see Item 4)
 
(9) Aggregate amount beneficially owned by each reporting person
2,229,955 (see Item 4)
 
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)
 
(11) Percent of class represented by amount in Row (9)     2.7% (see Item 4)
 
(12) Type of reporting person (see instructions)     IN
 





4


Item 1(a) Name of issuer:


Summit Therapeutics PLC


Item 1(b) Address of issuer's principal executive offices:


136A Eastern Avenue, Milton Park, Abingdon, Oxfordshire, United Kingdom OX14 4SB


2(a) Name of person filing:
This statement is filed by: (i) Point72 Asset Management, L.P. (“Point72 Asset
Management”) with respect to ADS, each representing five (5) ordinary shares,

par value £0.01 per share
 (“ Ordinary Shares”), of the Issuer held by certain

investment funds it manages; (ii)
Point72 Capital Advisors, Inc. (“Point72 Capital

Advisors Inc.”) with respect
to ADS held by certain investment funds managed by

Point72 Asset
Management; and (iii) Steven A. Cohen (“Mr. Cohen”) with respect

to ADS
beneficially owned by Point72 Asset Management and Point72 Capital

Advisors
Inc.
2(b) Address or principal business office or, if none, residence:
The address of the principal business office of Point72 Asset Management,
Point72 Capital Advisors Inc., and Mr. Cohen is 72 Cummings Point Road,
Stamford, CT 06902.
2(c) Citizenship:
Point72 Asset Management is a Delaware limited partnership. Point72 Capital Advisors
Inc. is a Delaware corporation. Mr. Cohen is a United States citizen.
2(d) Title of class of securities:

American Depositary Shares each representing five (5) Ordinary Shares, Par Value £0.01 Per Share

2(e) CUSIP Number:

86627R102


5


Item 3.

Not applicable

Item 4. Ownership

As of the close of business on December 31, 2018:

1. Point72 Asset Management, L.P.
(a) Amount beneficially owned: 2,229,955
(b) Percent of class: 2.7% 
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote: 0
(ii) Shared power to vote or to direct the vote: 2,229,955 
(iii) Sole power to dispose or to direct the disposition of: 0
(iv) Shared power to dispose or to direct the disposition of: 2,229,955

2. Point72 Capital Advisors, Inc.
(a) Amount beneficially owned: 2,229,955
(b) Percent of class: 2.7% 
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote: 0
(ii) Shared power to vote or to direct the vote: 2,229,955 
(iii) Sole power to dispose or to direct the disposition of: 0
(iv) Shared power to dispose or to direct the disposition of: 2,229,955

3. Steven A. Cohen
(a) Amount beneficially owned: 2,229,955
(b) Percent of class: 2.7% 
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote: 0
(ii) Shared power to vote or to direct the vote: 2,229,955 
(iii) Sole power to dispose or to direct the disposition of: 0
(iv) Shared power to dispose or to direct the disposition of: 2,229,955

Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen own
directly no ADS or Ordinary Shares. Pursuant to an investment management agreement, Point72
Asset Management maintains investment and voting power with respect to the
securities held by certain investment funds it manages. Point72 Capital
Advisors Inc. is the general partner of Point72 Asset Management. Mr. Cohen
controls each of Point72 Asset Management and Point72 Capital Advisors Inc.
As of December 31, 2018, by reason of the provisions of Rule 13d-3 of the Securities Exchange
Act of 1934, as amended, each of Point72 Asset Management, Point72 Capital Advisors
Inc. and Mr. Cohen may be deemed to beneficially own 2,229,955 Ordinary Shares
(constituting approximately 2.7% of the Ordinary Shares outstanding). Each of Point72
Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen disclaims
beneficial ownership of any of the securities covered by this statement.
6


Item 5. Ownership of 5 Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof
the reporting person has ceased to be the beneficial owner of more than
5 percent of the class of securities, check the following [X].

Item 6.  Ownership of More than 5 Percent on Behalf of Another Person.

Not applicable

Item 7.  Identification and Classification of the Subsidiary Which Acquired
the Security Being Reporting on by the Parent Holding Company or Control
Person.

Not applicable
Item 8. Identification and Classification of Members of the Group

Not applicable

Item 9.  Notice of Dissolution of Group.

Not applicable

Item 10. Certifications

By signing below I certify that, to the best of his/her knowledge and belief,
the securities referred to above were not acquired and are not held for the purpose
of or with the effect of changing or influencing the control of the issuer of
the securities and were not acquired and are not held in connection with or
as a participant in any transaction having that purpose or effect.


7


Signature.  After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete
and correct.

Dated: February 14, 2019

POINT72 ASSET MANAGEMENT, L.P.
By: /s/ Jason M. Colombo
Name: Jason M. Colombo
Title: Authorized Person

POINT72 CAPITAL ADVISORS, INC.
By: /s/ Jason M. Colombo
Name: Jason M. Colombo
Title: Authorized Person

STEVEN A. COHEN
By: /s/ Jason M. Colombo
Name: Jason M. Colombo
Title: Authorized Person






8